Objective-Vascular lineage differentiation of stem/progenitor cells can contribute to both tissue repair and exacerbation of vascular diseases such as in vein grafts. The role of macrophages in controlling vascular progenitor differentiation is largely unknown and may play an important role in graft development. This study aims to identify the role of macrophages in vascular stem/progenitor cell differentiation and thereafter elucidate the mechanisms that are involved in the macrophagemediated process. Approach and Results-We provide in vitro evidence that macrophages can induce endothelial cell (EC) differentiation of the stem/progenitor cells while simultaneously inhibiting their smooth muscle cell differentiation. Mechanistically, both effects were mediated by macrophage-derived tumor necrosis factor-α (TNF-α) via TNF-α receptor 1 and canonical nuclear factor-κB activation. Although the overexpression of p65 enhanced EC (or attenuated smooth muscle cell) differentiation, p65 or TNF-α receptor 1 knockdown using lentiviral short hairpin RNA inhibited EC (or rescued smooth muscle cell) differentiation in response to TNF-α. Furthermore, TNF-α-mediated EC differentiation was driven by direct binding of nuclear factor-κB (p65) to specific VE-cadherin promoter sequences. Subsequent experiments using an ex vivo decellularized vessel scaffold confirmed an increase in the number of ECs and reduction in smooth muscle cell marker expression in the presence of TNF-α. The lack of TNF-α in a knockout mouse model of vein graft decreased endothelialization and significantly increased thrombosis formation. Conclusions-Our study highlights the role of macrophages in directing vascular stem/progenitor cell lineage commitment through TNF-α-mediated TNF-α receptor 1 and nuclear factor-κB activation that is likely required for endothelial repair in vascular diseases such as vein graft. 
V ein grafts have predominantly been used in surgical interventions of vascular diseases, but their patency rate is often limited by graft failure attributable to the development of atherosclerosis-like lesions in the intima. 1 The occurrence of the lesions is mainly fueled by endothelial damage and death that subsequently leads to the infiltration of mononuclear cells such as macrophages from the blood into the neointima, thereby propagating an inflammatory milieu. [2] [3] [4] [5] [6] Activation of macrophages in the intima leads to the secretion of proinflammatory molecules such as tumor necrosis factor-α (TNF-α) and interleukin-1. 7, 8 At present, little is known about the role of macrophages in vascular regeneration and neointimal formation of vein grafts.
Recently, there has been considerable interest in a population of stem/progenitor cells within vessel compartments that can play crucial roles in vascular diseases. 9, 10 Using a mouse decellularized vessel graft model, Tsai et al 11 found a marked accumulation of cells that were positive for progenitor markers (Sca-1, c-kit, and CD34) within neointimal lesions. Interestingly, the progenitor cells could differentiate into either endothelial cells (ECs) or smooth muscle cells (SMCs) under specific stimulus. 11, 12 Furthermore, Sca-1 + resident progenitor cells were also found to be present within the adventitia. 13 Contrary to the notion that stem/progenitor cells can contribute to the pathogenesis of atherosclerosis, 14 there is also substantial evidence that these cells can simultaneously play reparative and atheroprotective roles. 15, 16 It is therefore vital to understand the effect of the inflammatory microenvironment on the differentiation of progenitor cells for subsequent designs of more effective therapeutic interventions using vein grafts.
Considering that macrophages are largely involved in vascular inflammation and are critical for the development of vascular diseases, 17 we aimed to address their role in the plasticity of stem/progenitor cells into a predominant vascular lineage and to identify the mechanisms that are involved in this process. We provide novel evidence that macrophages are able to control stem/progenitor cell vascular lineage commitment by inducing EC differentiation while simultaneously inhibiting SMC differentiation. Furthermore, we show that the control of stem/progenitor cell differentiation by macrophages is fundamentally driven by TNF-α via TNF-α receptor 1 (TNF-R1) and canonical nuclear factor-κB (NF-κB) signaling pathways.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Macrophages Induce Progenitor and Stem Cell-Endothelial Differentiation Through TNF-α
To investigate the potential effects of macrophages on vascular progenitor cell differentiation, peritoneal macrophages were cocultured with Sca-1 + Lin − progenitor cells that were obtained and characterized using previously defined methods. [11] [12] [13] The coculture was performed in the presence of a 0.4-μm membrane insert to prevent physical contact between the 2 cell types. Data revealed that the presence of macrophages caused a significant induction in the transcriptional expression of a panel of endothelial markers such as PECAM1, VE-cadherin, and Flk-1 ( Figure 1A) . Consistently, an increase of the endothelial NO synthase cell surface expression was also detected ( Figure 1B ). Previous work from our laboratory has established the capacity of murine embryonic stem cell-derived Sca-1 + progenitors to differentiate into both SMC and EC lineages under specific culture conditions. 18, 19 Therefore, we also sought to use these stem cells in parallel with progenitor cells to elucidate the role(s) of macrophages in vascular lineage differentiation. Interestingly, our data showed significant upregulation of endothelial markers in stem cells cultured with macrophages, both at mRNA ( Figure 1C ) and protein levels ( Figure 1D ).
To identify macrophage-derived secretory factors that are responsible for induction of stem/progenitor EC differentiation, a Multi-Analyte ELISArray was performed using conditioned media (CM) from peritoneal macrophages. We observed markedly high levels of TNF-α within the macrophage CM ( Figure 1E ). Subsequent assays using TNF-α ELISA confirmed that macrophage CM contained 1113.29±5.136 pg/ mL of TNF-α, whereas complete culture media contained 1.94±0.156 pg/mL. To this point, we performed experiments in parallel using a macrophage cell line J774.1 and found that the results were indistinguishable from those using peritoneal macrophages, including J774.1 macrophage-mediated induction of endothelial expression by both progenitor and stem cells ( Figure I in the online-only Data Supplement). Therefore, because of ease of macrophage culture and propagation, we performed subsequent experiments using J774.1 macrophages.
To evaluate whether TNF-α may directly induce stem/progenitor cell differentiation, a neutralizing antibody to TNF-α was added into the stem cell/macrophage cocultures. Data showed that macrophage-mediated EC differentiation was abrogated in the presence of the anti-TNF-α antibody, but not with an anti-IgG1 control antibody ( Figure 1F) . Furthermore, the addition of exogenous TNF-α (1, 10, or 100 ng/mL) to stem cells alone caused a dose-dependent increment of EC markers at transcriptional ( Figure 1G ) and protein levels ( Figure 1H ). The increment of EC markers in response to TNF-α was specific to endothelial differentiation and was not a result of stem cell proliferation ( Figure II in the online-only Data Supplement). Notably, although interleukin-6 was also detected in CM of macrophages at a lower level ( Figure 1E ), experiments using recombinant interleukin-6 or interleukin-6 neutralizing antibodies showed that the cytokine was not involved in EC differentiation ( Figure III in the online-only Data Supplement).
Macrophage-Derived TNF-α Induces Differentiation of Sca-1 + Vascular Progenitors Into Functional ECs
Subsequent experiments were performed to ascertain the functionality of progenitor-derived ECs in response to TNF-α. Data showed that TNF-α-treated progenitor cells were able to form significantly higher numbers of tubes in in vitro (Figure 2A and 2B). Additional in vivo Matrigel assays showed increased formation of tubes and capillaries that expressed PECAM1 and VE-cadherin ( Figure 2C and 2D) in plugs that contained TNF-α pretreated progenitor cells. Interestingly, the expression of PECAM1 and VE-cadherin was found to colocalize specifically at cellular junctions of the ECs ( Figure 2E ), thus postulating that macrophage-derived TNF-α can mediate EC differentiation and vessel formation via junctional stabilization of progenitor ECs. Next, we labeled progenitor cells (+/−TNF-α) with Qdot 625 nanocrystals before injecting the Matrigel plugs into mice to evaluate whether the increase of PECAM1 + and VE-cadherin Figure 2G and 2H) . Furthermore, only TNF-α-treated plugs showed positive staining with lectin, a marker of functional blood vessel formation ( Figure 2I ). Taken together, the results confirm that macrophage-derived TNF-α can induce the differentiation of vascular progenitor cells into functional ECs.
TNF-α-Induced Differentiation Is Mediated by TNF-R1 via Canonical NF-κB (p65) Signaling
Subsequent experiments confirmed that stem cells treated either with macrophages or TNF-α had significantly enhanced TNF-R1 expression ( Figure 3A) . Interestingly, treatment with macrophages or TNF-α caused a marked increment of canonical NF-κB signaling markers (p65 and p50), whereas the levels of noncanonical NF-κB proteins (Rel-B, NIK, and p52/p100) did not change ( Figure 3B ). To confirm the role of TNF-R1 and canonical NF-κB in the TNF-α-mediated effects, we ablated either TNF-R1 or p65 in stem cells using lentiviral short hairpin RNA. TNF-R1 short hairpin RNA knockdown led to a marked decrease of both TNF-R1 and p65 expression following stimulation of stem cells with TNF-α; both PECAM1 and VE-cadherin expression were also reduced ( Figure 3C ). In addition, p65 short hairpin RNA knockdown in TNF-α-treated stem cells resulted in an evident reduction of p65 and VE-cadherin ( Figure 3D ), and the overexpression of p65 enhanced their expression of EC markers ( Figure 3E ). These data demonstrate the direct role of TNF-R1 and canonical NF-κB activation in TNF-α-mediated stem cell-EC differentiation. Because TNF-α treatment induced the nuclear translocation of p65 from the cytoplasm ( Figure IV in the online-only Data Supplement), we sought to investigate whether p65 translocation can directly activate endothelial promoters that lead to EC differentiation. Indeed, we found a dose-dependent increase of stem cell VE-cadherin promoter activity using a luciferase reporter assay, in response to TNF-α ( Figure V in the onlineonly Data Supplement) and an ablation of TNF-α-mediated promoter activation following TNF-R1 or p65 knockdown ( Figure 3F ). The overexpression of p65 significantly induced the promoter activation ( Figure 3G ). Using a ChIP assay, we detected specific binding of p65 to the VE-cadherin promoter region between −2504 and −2111 bp ( Figure 3H and Figure VI in the online-only Data Supplement). Thus, our study provides first evidence that TNF-α can directly stimulate VE-cadherin gene transcription that leads to endothelial differentiation through direct binding of NF-κB (p65) to the promoter region.
Macrophage-Derived TNF-α Inhibits SMC Differentiation Through TNF-R1 and NF-κB (p65) Signaling
To confirm the specificity of macrophage-derived TNF-α in inducing EC differentiation, stem cells were also tested for potential changes in SMC expression. Interestingly, the presence of either peritoneal macrophages or TNF-α resulted in a reduction of SMC marker expression in stem cells ( Figure 4A ), thus suggesting that macrophages or TNF-α may inhibit SMC differentiation. Using a collagen IV-mediated SMC differentiation protocol established by our laboratory, 18 we found that the presence of peritoneal macrophages and TNF-α can significantly inhibit stem cell-SMC differentiation ( Figure 4B and 4C). As before, we confirmed that results from experiments performed using the macrophage cell line J774.1 were undistinguishable from those using peritoneal macrophages, including macrophage-mediated inhibition of SMC differentiation in both stem ( Figure Anti-α-tubulin was used as a loading control. E, Conditioned media from peritoneal macrophages or controls were concentrated using a Ultracel YM-3 Centripep (3000 nominal molecular weight limit) and subjected to a Th1/Th2/Th17 Cytokines Multi-Analyte ELISArray assay. F, Total RNA was harvested from stem cells that were cocultured with J774.1 macrophages in the presence of an anti-tumor necrosis factor-α (TNF-α) monoclonal antibody (mAb; 10 μg/mL) before analysis with real-time RT-PCR. An anti-IgG1 mAb (10 μg/mL) was used as a control. Stem cells were cultured with an increasing concentration of recombinant murine TNF-α for 48 hours and subjected to (G) real-time RT-PCR analysis and (H) Western blotting. Immunofluorescent images whereas blots shown are representative of 3 independent experiments performed, whereas graphs are shown as mean±SEM of 3 independent experiments. *P<0.05; **P<0.01; ***P<0.005. Flk-1 indicates fetal liver kinase1; IFN-γ, interferon-γ; IL, interleukin; and TGF-β, transforming growth factor-β.
that SMC differentiated stem cells had significantly decreased activation of canonical-but not noncanonical-NF-κB signaling genes and protein ( Figure 4E and Figure VIII in the online-only Data Supplement). Furthermore, the knockdown of p65 led to the rescue of TNF-α-mediated inhibition of SMC differentiation ( Figure 4F ), whereas its overexpression caused an evident reduction ( Figure 4G ). Experiments using TNF-R1 short hairpin RNA also revealed a rescue of SMC expression ( Figure 4F ). Together, the results demonstrate that macrophage-derived TNF-α can induce stem/progenitor-EC differentiation while inhibiting their SMC lineage through TNF-R1 and NF-κB signaling pathways.
TNF-α Is Directly Involved in Controlling the Lineage Commitment of Vascular Progenitor Cells
To confirm our in vitro results in a physiological environment, stem cells were seeded within a decellularized vessel graft bioreactor system in the presence of TNF-α and subsequently evaluated for their differentiation into EC or SMC lineages under the same flow rate. Interestingly, we found markedly increased numbers of cells that lined the luminal area of TNF-α-treated vessels, as visualized by hematoxylin-eosin staining ( Figure 5A ; black arrows). Next, we performed immunofluorescence staining on the same vessels with EC and SMC markers to identify the cell types within. When compared with the control vessels, we observed significantly higher number of PECAM1-positive cells on the luminal side of TNF-α-treated vessels as compared with control vessels. Accordingly, the number of calponin-positive cells that resided in the medial layer was significantly reduced in TNF-α-treated vessels ( Figure 5B) . Consistently, the TNF-α-treated vessels contained significantly higher numbers of VE-cadherin-positive cells and markedly less SM α-actin-positive cells as compared with control vessels ( Figure 5C ).
Macrophage-Derived TNF-α Is Responsible for Endothelial Repair and Neointimal Formation in Vein Grafts
To validate our rationale in vivo, we performed subsequent vein grafting experiments using TNF-α-deficient mice. Next, we sought to validate the effects of TNF-α deficiency specifically in bone marrow (BM) cells-a population from which macrophage/monocytic lineages are derived. We created a chimeric mouse model whereby BM cells from either TNF-α −/− or TNF-α +/+ mice were harvested and transferred into irradiated wild-type mice. The efficacy of the chimeric model has previously been confirmed, in which we saw >95% of recipient BM cells being replaced by donor-derived BM cells. 20 Vein segments from wild-type mice were grafted into chimeric mice with either TNF-α +/+ or TNF-α −/− BM. Consistently, only wild-type animals that received TNF-α −/− BM cells had markedly increased thrombosis and reduced endothelial area 4 weeks after grafting (Figure 6Di , 6Dii, and Figure 3 . Macrophage-derived tumor necrosis factor-α (TNF-α) mediates endothelial differentiation through TNF-α receptor 1 (TNF-R1) activation and direct binding of canonical nuclear factor-κB (NF-κB; p65) to VE-cadherin promoter sequences. Real-time reverse transcription polymerase chain reaction (PCR) was performed for analysis of TNF-R1 gene expression (A), and cell lysates were subjected to Western blotting for detection of canonical NF-κB (p65, p50) and noncanonical NF-κB (Rel-B, NF-κB-inducing kinase [NIK], p52/ p100) proteins (B). Stem cells were infected either with lentiviral short hairpin RNA (shRNA) for ablation of (C) TNF-R1 and (D) p65 and treated with TNF-α for 48 hours or (E) subjected to the overexpression of p65 gene using plasmid transfection, before analysis of endothelial protein expression using Western blot. F, Stem cells were treated with TNF-α after transfection with a pGL3-VE-cadherin (2.4 kb) promoter reporter gene (0.33 μg/well) after lentiviral shRNA knockdown of TNF-R1 and p65. pRenilla (0.1 μg/5×10 4 cells) was included as luciferase plasmid control. Luciferase and Renilla activity assays were detected 48 hours after transfection. G, Stem cells were also transfected in combination with a pcDNA3-p65 expression plasmid (0.16 μg/well) before detection of luciferase and Renilla activities. H, Chromatin immunoprecipitation assay was performed using an antibody against p65 with an appropriate IgG as a negative control. Aliquots of chromatin before immunoprecipitation served as an input control. The assay revealed that p65 binds directly to the VE-cadherin gene promoter at region (−2504 and −2111) nucleotides (nt) upstream of the transcription initiation site in TNF-α-treated stem cells. Blots and PCR gel shown are representative of 3 independent experiments, and graphs are shown as mean±SEM of 3 independent experiments. *P<0.05 compared with control. NC indicates noncoding; PECAM1, platelet endothelial cell adhesion molecule 1; and RLU, relative light units. ) were seeded within a previously decellularized vessel graft in the presence or absence of TNF-α for 12 hours followed by the application of shear stress. A, The grafts were harvested and embedded in mouse liver for liquid nitrogen freezing before being stained with hematoxylin-eosin (left, bar=10 μm; right, bar=100 μm). The frozen sections were also subjected to immunofluorescence staining and quantification of both endothelial cell-and smooth muscle cell-positive cells. The occurrence of thrombosis in the vein grafts resulted in a decrease in blood flow and cellular gradient within the vessels and is therefore likely the cause of decrease in neointimal formation.
These data strongly suggest that during later stages of vein grafting, TNF-α is increasingly secreted by inflammatory mediators such as macrophages; the release of this proinflammatory cytokine is critical for the prevention of thrombosis. Concomitantly, it is likely that the prevention of thrombosis by TNF-α is mediated through the maintenance of endothelium integrity by controlling the lineage differentiation of stem/progenitor cells that are present within the neointima of vein grafts into ECs.
Discussion
The establishment of vein graft pathogenesis is fueled by a time-dependent change of cellular composition within the grafts, which includes a progressive increment of >20 layers of cells and matrix protein deposition ( Figure XIIIA in the online-only Data Supplement). Within growing neointimal lesions, a high number of macrophages and also a consistent, albeit small, population of Sca-1 + progenitor cells have been identified (Figure XIIIB and XIIIC in the online-only Data Supplement). To date, the putative interaction between macrophages and vascular progenitor cells and its potential role in vein graft atherosclerosis are not known. In the present study, we provide first evidence that macrophages can control vascular stem/progenitor cells for specific differentiation into ECs, independent of physical contact. Furthermore, our study highlights the potential of macrophages to simultaneously inhibit progenitor/stem cell differentiation into SMCs. We demonstrate that the remarkable dual effect of macrophages is directly mediated through the secretion of TNF-α. Consistent with our results, several studies have previously demonstrated the role of macrophage-derived TNF-α in mediating angiogenesis following injury 22 or in tumorigenic conditions, 23 likely mediated through the secretion of angiogenic factors such as vascular endothelial growth factor (VEGF), angiopoietin-1, hepatocyte growth factor, and bone morphogenetic protein-2. 22, 24, 25 In light of these data, we found that macrophage CM contained a panel of angiogenic factors and chemokines including VEGF-A, VEGF-C, monocyte chemotactic protein-1, macrophage inflammatory protein-1α, and macrophage inflammatory protein-1β ( Figure XIV in the online-only Data Supplement). Nevertheless, subsequent experiments showed that most of the angiogenic factors (ie, VEGF-A and VEGF-C) were not involved in macrophagemediated EC differentiation ( Figure XV in the online-only Data Supplement). Notably, stem/progenitor-EC differentiation and interactions with macrophages may also be facilitated by their migration and chemotactic responses toward TNF-α. 26 Although previous studies have shown that the occurrence of thrombosis could be attenuated at later stages of vascular grafts in which an intact endothelium can also be found, 1 ,2 the precise cellular responses responsible for the observations remain unclear. The present findings showed that either vein grafts in TNF-α −/− mice or vein grafts with TNF-α −/− BM cells resulted in the absence of endothelial regeneration that led to severe thrombosis. During this time point, other investigators including ourselves have demonstrated the presence of a large number of infiltrated macrophages and high levels of TNF-α in the media/neointima of vein grafts. 6, 27 Therefore, macrophages are likely to promote endothelial repair via TNF-α that also lead to reduced thrombotic events. It is however noteworthy that the direct administration of TNF-α in a mouse model of ferric chloride-induced arterial injury was also found to induce antithrombotic effects that were independent of any cellular differentiation. 28 In the present study, we also showed that TNF-α was required for neointimal lesion formation because its deficiency markedly ablates the presence of neointima. This was not surprising because TNF-α deficiency was likely to inhibit the migration and proliferation of other key drivers of neointimal hyperplasia, namely mature SMC. 27 Contrary to traditional belief that macrophages are key promoters of atherosclerosis, our results showed that macrophages and its secreted effectors may be required to initiate a reparative response by inducing EC differentiation from a population of stem/progenitor cells during later stages of vein grafts. This concept is of increasing relevance given recent accruing evidence demonstrating that different populations of macrophages with defined phenotypes and functions exist in neointimal lesions. 17 Figure 6B and 6C and Figure XI in the online-only Data Supplement). Although it is tempting to postulate that M1 macrophages are largely responsible for inducing EC repair in late-stage vein grafts, further work is still required to confirm the intriguing findings.
Torres and Watt 30 previously demonstrated that the withdrawal of the pluripotency growth factor, leukemia inhibitory factor, resulted in an upregulation of NF-κB signaling that is concomitant with mouse stem cell differentiation. Although the lineage specificity of stem cell differentiation was not clarified by the authors, we show that the switching on of canonical NF-κB via TNF-R1 activation results in definitive differentiation toward the endothelial route by direct binding of p65 to specific elements of the VE-cadherin promoter. Furthermore, we identified that the induction of endothelial and inhibition of SMC differentiation by macrophage-derived TNF-α were directly regulated by canonical NF-κB signaling. We could not detect significant changes in the activities of noncanonical NF-κB signaling proteins, potentially because they are mainly involved in maintaining stem cell pluripotency. 31 Furthermore, although studies also indicate a putative role of TNF-α/ TNF-R1/NF-κB in regulating the survival of other cell types, 32 our in vitro and in vivo data did not show any significant rescue of stem/progenitor apoptosis after TNF-α treatment ( Figure XVI in the online-only Data Supplement). Collectively, data from our study provide novel evidence that canonical NF-κB can act as a genetic switch that is responsible for controlling the specific lineage commitment (plasticity) of a vascular progenitor cell. Nevertheless, the field still remains in its infancy because suitable mouse models that enable lineage tracing of the Sca-1 + progenitor cells are still required to fully comprehend the roles of progenitor cell plasticity/differentiation during specific stages of pathology.
In summary, the present study provides evidence of the coexistence of macrophages and progenitor cells in the neointima during pathological conditions of vein grafts. We demonstrated that macrophage-derived TNF-α can activate TNF-R1/canonical NF-κB signaling pathways that lead to the simultaneous induction of EC differentiation and SMC suppression of stem/progenitor cells. Using a TNF-α −/− vein graft mouse model, we demonstrated a role of TNF-α in promoting vein graft endothelial repair, while preventing thrombus formation. Together, our data provide crucial evidence that will increase the understanding of the mechanisms by which vascular progenitor plasticity can be controlled. This can, therefore, expedite the identification of cellular/molecular targets that will lead to more efficient strategies for vascular interventions for vein graft failure.
